Clinical trial · Observational
Pathway to Diagnosis of Ovarian Cancer
Pathway to Diagnosis of Ovarian Cancer: Observational Retrospective Multicenter Study
NCT01061619CI-TRIAL-00064994MITO-12unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to describe the prediagnostic symptoms and the events along the pathway to diagnosis of women with ovarian cancer, referred for first-line chemotherapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- the frequency and duration of symptoms in 12 months preceding ovarian cancer diagnosis
- timeFrame
- at baseline
- measure
- time intervals in weeks between prediagnostic sentinel events (onset of persistent symptoms, first physician visit, diagnosis of ovarian cancer)
- timeFrame
- at baseline
- measure
- description of prediagnostic patient experiences according to modified Andersen's model of 'total patient delay'
- timeFrame
- at baseline
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histological diagnosis of ovarian cancer * Indication for chemotherapy * Age \> 18 years * Signed informed consent Exclusion Criteria: * Previous chemotherapy * Unable or unwilling to participate in interview
References
Publications (0)
Data not yet available
No reference posted for this study.